YARW

YARROW BIOSCIENCE, INC.

• TipRanks·12h ago

  Molson Coors downgraded, SiTime upgraded: Wall Street’s top analyst calls

• TipRanks·16h ago

  Yarrow Bioscience initiated with a Buy at Guggenheim

• Seeking Alpha·1d ago

  Viridian Therapeutics: Strong Start For Lumvoa, VRDN-008 Data Ahead

• Seeking Alpha·10/29 19:12

  Russell 2000 estimated to add 107 stocks in December rebalance - Stephens

• TipRanks·09/14 20:37

  Yarrow Bioscience Announces Underwritten Equity Offering Agreement

• Seeking Alpha·09/11 07:10

  Yarrow Bioscience prices $150M public offering of common stock at $26 per share

• Dow Jones·09/11 01:32

  *Yarrow Bioscience Offering Is Expected to Close on September 14 >YARW

• Dow Jones·09/11 01:32

  *Jefferies, TD Cowen, Guggenheim Securities Among Mangers for Offering >YARW

• Dow Jones·09/11 01:32

  *Yarrow Bioscience Intends to Use Proceeds to Fund R&D Expenses for Pipeline >YARW

• Dow Jones·09/11 01:31

  *Yarrow Bioscience Has Granted Underwriters Option for Additional 865,384 Shares >YARW

• Dow Jones·09/11 01:31

  *Yarrow Bioscience Offering of 5,769,231 Shares Priced at $26.00 Each >YARW

• TipRanks·09/11 01:20

  Yarrow Bioscience 5.77M share Spot Secondary priced at $26.00

• TipRanks·09/10 20:38

  Yarrow Bioscience Updates Strategy for Thyroid Autoimmune Pipeline

• TipRanks·09/10 20:05

  Yarrow Bioscience announces common stock offering, no amount given